Growth Hormone Deficiency Market

Growth Hormone Deficiency Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 299

To learn more about this report, request a free sample copy

Growth Hormone Deficiency Market Overview

The report is titled as ‘Growth Hormone Deficiency Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the growth hormone deficiency market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The growth hormone deficiency market is expected to grow at a significant rate in the near future.

Growth Hormone Deficiency Introduction

A normal human height is governed by interactions among various factors such as nutritional status, genetic predisposition, environmental factors, and hormonal secretion. Conventionally, short stature has been indent as a height of two standard deviations (SD) below the average of age, sex, and ethnic-matched healthy commands, and is a invariable reason for reference to pediatric endocrinologists.

Growth hormone deficiency (GHD) is a rare but essential cause of short stature with a prevalence of just about one in 4000 in the course of childhood. Although it is a highly unique medical condition, it is crucial to make an accurate diagnosis in order to initiate substitutive recombinant human (rh) GH therapeutic right away and attain a standardization of child development.

As a matter of fact, lacking a diagnosis is estimated to result in inferior or inadequate growth and short stature adults. On the contrary, a deceitful positive diagnosis might lead to several years of regular hypodermic injections and considerable inessential expenditure.

Growth Hormone Deficiency Market Dynamics

The rising incidence of growth hormone (GH) deficiency has become a strain for the healthcare industry in the past couple of years, which is majorly bolstering the growth of the global growth hormone deficiency market.

By the same token, the GH deficiency has also resulted in further chronic disorders, including different body physique, lower muscle strength and energy levels, and other abnormalities which is likely to lead to brain injury, in the near future, which is also playing a part in positively fueling the growth of the global growth hormone deficiency market.

However, there are certain side-effects of GH drugs which might be harmful for the patients, such as fluid retention, joint pain, and muscle pain, which is likely to slow down the growth of the global growth hormone deficiency market in the years to come.

Growth Hormone Deficiency Market Segmentation

The global growth hormone deficiency market is segmented on the basis of application, treatment type, end-user, distribution channel and region. The application segment of the growth hormone deficiency market is divided into adult growth hormone deficiency and pediatric growth hormone deficiency. Furthermore, the treatment type segment is divided into Surgery and Growth Hormone Therapy. On the basis of end-user, the market is segmented into Hospitals, Clinics, and Homecare settings. On the basis of the distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.

Growth Hormone Deficiency Market Key Players

The global growth hormone deficiency market is dominated by Sandoz International GmbH, Sanofi-Aventis, Pfizer, Novo Nordisk A/S, Teva Pharmaceutical Industries Limited, Ranbaxy, EMD Serono, Inc., Sun Pharmaceutical Industries Ltd., Eli Lilly and Company, Ferring Holding SA, Genentech, Inc., Merck & Co., Inc., Ipsen, GeneScience Pharmaceuticals Co., Ltd., and Roche Holdings, Inc., among others.

MMC Overview on Growth Hormone Deficiency Market Report

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.

A research report on the growth hormone deficiency market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

New product designs and launches

Current product compliance

Reimbursement

Concerns for use of growth hormone deficiency

Advantages of growth hormone deficiency

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make informed decisions.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.


To learn more about this report, request a free sample copy


1.    Global Growth Hormone Deficiency Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Growth Hormone Deficiency Market Overview

2.1.    Introduction

2.1.1.    Introduction

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Growth Hormone Deficiency Market Snapshot

2.4.    Global Growth Hormone Deficiency Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast And Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Growth Hormone Deficiency Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Porter’s Five Forces Model

2.7.    SWOT Analysis

3.    Growth Hormone Deficiency Assessment and Analysis

3.1.    Growth Hormone Deficiency Impact Analysis 

3.2.    Actions to encourage use of Growth Hormone Deficiency

3.3.    Growth Hormone Deficiency Promotional Strategy Recommendation

3.4.    Road Map Analysis

3.5.    GAP Analysis

3.6.    Potential Analysis

4.    Covid-19 Impact on Growth Hormone Deficiency Market

4.1.    Impact Analysis of Covid-19 on the global Growth Hormone Deficiency market

4.2.    Effect On Value Chain

4.3.    Business Impact W.R.T Revenue 

4.4.    Volatility in Price 

4.5.    Effect On The Overall Trade 

4.6.    Market Impact Analysis In 2020 (Quarter Wise)

5.    Global Growth Hormone Deficiency Market, By Application

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Application

5.1.2.    BPS Analysis, By Application

5.2.    Market Revenue (US$ Mn) and Forecast, By Application

5.2.1.    Adult Growth Hormone Deficiency

5.2.2.    Pediatric Growth Hormone Deficiency

5.3.    Global Growth Hormone Deficiency Market Attractiveness Index, By Application

6.    Global Growth Hormone Deficiency Market, By Treatment Type

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Treatment Type

6.1.2.    BPS Analysis, By Treatment Type

6.2.    Market Revenue (US$ Mn) and Forecast, By Treatment Type

6.2.1.    Surgery

6.2.2.    Growth Hormone Therapy

6.3.    Global Growth Hormone Deficiency Market Attractiveness Index, By Treatment Type

7.    Global Growth Hormone Deficiency Market, By End-Users

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By End-Users

7.1.2.    BPS Analysis, By End-Users

7.2.    Market Revenue (US$ Mn) and Forecast, By End-Users

7.2.1.    Hospitals

7.2.2.    Clinics

7.2.3.    Homecare Settings

7.3.    Global Growth Hormone Deficiency Market Attractiveness Index, By End-Users

8.    Global Growth Hormone Deficiency Market, By Distribution Channels

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Distribution Channels

8.1.2.    BPS Analysis, By Distribution Channels

8.2.    Market Revenue (US$ Mn) and Forecast, By Distribution Channels

8.2.1.    Hospital Pharmacies

8.2.2.    Retail Pharmacies

8.2.3.    Online Pharmacies

8.3.    Global Growth Hormone Deficiency Market Attractiveness Index, By Distribution Channels

9.    Global Growth Hormone Deficiency Market, By Region

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Region

9.1.2.    BPS Analysis, By Region

9.2.    Market Revenue (US$ Mn) and Forecast, By Region

9.2.1.    North America

9.2.2.    Latin America

9.2.3.    Europe

9.2.4.    Asia Pacific

9.2.5.    Middle East 

9.2.6.    Africa

9.3.    Global Growth Hormone Deficiency Market Attractiveness Index, By Region

10.    North America Growth Hormone Deficiency Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market Revenue (US$ Mn) and Forecast, By Country

10.2.1.    U.S. Growth Hormone Deficiency Market

10.2.2.    Canada Growth Hormone Deficiency Market

10.3.    North America Growth Hormone Deficiency Market, By Application

10.3.1.    Adult Growth Hormone Deficiency

10.3.2.    Pediatric Growth Hormone Deficiency

10.4.    North America Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By Treatment Type

10.4.1.    Surgery

10.4.2.    Growth Hormone Therapy

10.5.    North America Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By End-Users

10.5.1.    Hospitals

10.5.2.    Clinics

10.5.3.    Homecare Settings

10.6.    North America Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By Distribution Channels

10.6.1.    Hospital Pharmacies

10.6.2.    Retail Pharmacies

10.6.3.    Online Pharmacies

10.7.    North America Growth Hormone Deficiency Market Attractiveness Index

10.7.1.    By Country

10.7.2.    By Application

10.7.3.    By Treatment Type

10.7.4.    By End-Users

10.7.5.    By Distribution Channels

11.    Latin America Growth Hormone Deficiency Market Analysis and Forecast, 2020–2028

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$ Mn) Forecast, By Country

11.2.1.    Brazil Growth Hormone Deficiency Market

11.2.2.    Mexico Growth Hormone Deficiency Market

11.2.3.    Rest of Latin America Growth Hormone Deficiency Market

11.3.    Latin America Growth Hormone Deficiency Market, By Application

11.3.1.    Adult Growth Hormone Deficiency

11.3.2.    Pediatric Growth Hormone Deficiency

11.4.    Latin America Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By Treatment Type

11.4.1.    Surgery

11.4.2.    Growth Hormone Therapy

11.5.    Latin America Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By End-Users

11.5.1.    Hospitals

11.5.2.    Clinics

11.5.3.    Homecare Settings

11.6.    Latin America Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By Distribution Channels

11.6.1.    Hospital Pharmacies

11.6.2.    Retail Pharmacies

11.6.3.    Online Pharmacies

11.7.    Latin America Growth Hormone Deficiency Market Attractiveness Index

11.7.1.    By Country

11.7.2.    By Application

11.7.3.    By Treatment Type

11.7.4.    By End-Users

11.7.5.    By Distribution Channels

12.    Europe Growth Hormone Deficiency Market Analysis and Forecast, 2020–2028

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$ Mn) Forecast, By Country

12.2.1.    U.K. Growth Hormone Deficiency Market

12.2.2.    Germany Growth Hormone Deficiency Market

12.2.3.    Italy Growth Hormone Deficiency Market

12.2.4.    France Growth Hormone Deficiency Market

12.2.5.    Spain Growth Hormone Deficiency Market

12.2.6.    Russia Growth Hormone Deficiency Market

12.2.7.    Rest of Europe Growth Hormone Deficiency Market

12.3.    Europe Growth Hormone Deficiency Market, By Application

12.3.1.    Adult Growth Hormone Deficiency

12.3.2.    Pediatric Growth Hormone Deficiency

12.4.    Europe Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By Treatment Type

12.4.1.    Surgery

12.4.2.    Growth Hormone Therapy

12.5.    Europe Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By End-Users

12.5.1.    Hospitals

12.5.2.    Clinics

12.5.3.    Homecare Settings

12.6.    Europe Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By Distribution Channels

12.6.1.    Hospital Pharmacies

12.6.2.    Retail Pharmacies

12.6.3.    Online Pharmacies

12.7.    Europe Growth Hormone Deficiency Market Attractiveness Index

12.7.1.    By Country

12.7.2.    By Application

12.7.3.    By Treatment Type

12.7.4.    By End-Users

12.7.5.    By Distribution Channels

13.    Asia Pacific Growth Hormone Deficiency Market Analysis and Forecast, 2020–2028

13.1.    Introduction

13.1.1.    Annual Growth Rate Comparison, By Country

13.1.2.    BPS Analysis, By Country

13.2.    Market (US$ Mn) Forecast, By Country

13.2.1.    China Growth Hormone Deficiency Market

13.2.2.    India Growth Hormone Deficiency Market

13.2.3.    Japan Growth Hormone Deficiency Market

13.2.4.    Australia and New Zealand Growth Hormone Deficiency Market

13.2.5.    South Korea Growth Hormone Deficiency Market

13.2.6.    Rest of Asia Pacific Growth Hormone Deficiency Market

13.3.    Asia Pacific Growth Hormone Deficiency Market, By Application

13.3.1.    Adult Growth Hormone Deficiency

13.3.2.    Pediatric Growth Hormone Deficiency

13.4.    Asia Pacific Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By Treatment Type

13.4.1.    Surgery

13.4.2.    Growth Hormone Therapy

13.5.    Asia Pacific Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By End-Users

13.5.1.    Hospitals

13.5.2.    Clinics

13.5.3.    Homecare Settings

13.6.    Asia Pacific Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By Distribution Channels

13.6.1.    Hospital Pharmacies

13.6.2.    Retail Pharmacies

13.6.3.    Online Pharmacies

13.7.    Asia Pacific Growth Hormone Deficiency Market Attractiveness Index

13.7.1.    By Country

13.7.2.    By Application

13.7.3.    By Treatment Type

13.7.4.    By End-Users

13.7.5.    By Distribution Channels

14.    Middle East Growth Hormone Deficiency Market Analysis and Forecast, 2020–2028

14.1.    Introduction

14.1.1.    Annual Growth Rate Comparison, By Country

14.1.2.    BPS Analysis, By Country

14.2.    Market (US$ Mn) Forecast, By Country

14.2.1.    GCC Countries Growth Hormone Deficiency Market

14.2.2.    Israel Growth Hormone Deficiency Market

14.2.3.    Rest of Middle East Growth Hormone Deficiency Market

14.3.    Middle East Growth Hormone Deficiency Market, By Application

14.3.1.    Adult Growth Hormone Deficiency

14.3.2.    Pediatric Growth Hormone Deficiency

14.4.    Middle East Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By Treatment Type

14.4.1.    Surgery

14.4.2.    Growth Hormone Therapy

14.5.    Middle East Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By End-Users

14.5.1.    Hospitals

14.5.2.    Clinics

14.5.3.    Homecare Settings

14.6.    Middle East Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By Distribution Channels

14.6.1.    Hospital Pharmacies

14.6.2.    Retail Pharmacies

14.6.3.    Online Pharmacies

14.7.    Middle East Growth Hormone Deficiency Market Attractiveness Index

14.7.1.    By Country

14.7.2.    By Application

14.7.3.    By Treatment Type

14.7.4.    By End-Users

14.7.5.    By Distribution Channels

15.    Africa Growth Hormone Deficiency Market Analysis and Forecast, 2020–2028

15.1.    Introduction

15.1.1.    Annual Growth Rate Comparison, By Country

15.1.2.    BPS Analysis, By Country

15.2.    Market (US$ Mn) Forecast, By Country

15.2.1.    South Africa Countries Growth Hormone Deficiency Market

15.2.2.    Egypt Growth Hormone Deficiency Market

15.2.3.    North Africa Growth Hormone Deficiency Market

15.2.4.    Rest of Africa Growth Hormone Deficiency Market

15.3.    Africa Growth Hormone Deficiency Market, By Application

15.3.1.    Adult Growth Hormone Deficiency

15.3.2.    Pediatric Growth Hormone Deficiency

15.4.    Africa Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By Treatment Type

15.4.1.    Surgery

15.4.2.    Growth Hormone Therapy

15.5.    Africa Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By End-Users

15.5.1.    Hospitals

15.5.2.    Clinics

15.5.3.    Homecare Settings

15.6.    Africa Growth Hormone Deficiency Market Revenue (US$ Mn) and Forecast, By Distribution Channels

15.6.1.    Hospital Pharmacies

15.6.2.    Retail Pharmacies

15.6.3.    Online Pharmacies

15.7.    Africa Growth Hormone Deficiency Market Attractiveness Index

15.7.1.    By Country

15.7.2.    By Application

15.7.3.    By Treatment Type

15.7.4.    By End-Users

15.7.5.    By Distribution Channels

16.    Competitive Landscape

16.1.    Company Profiles

16.1.1.    Sandoz International GmbH

16.1.1.1.    Company Overview

16.1.1.2.    Financial Overview

16.1.1.3.    Key Developments

16.1.1.4.    Strategies

16.1.1.5.    Product Portfolio

16.1.2.    Sanofi-Aventis

16.1.3.    Pfizer

16.1.4.    Novo Nordisk A/S

16.1.5.    Teva Pharmaceutical Industries Limited

16.1.6.    Ranbaxy

16.1.7.    EMD Sereno Inc.

16.1.8.    Sun Pharmaceutical Industries Ltd.

16.1.9.    Eli Lilly and Company

16.1.10.    Ferring Holding SA

16.1.11.    Genentech Inc.

16.1.12.    Merck & Co. Inc.

16.1.13.    Ipsen

16.1.14.    GeneScience Pharmaceuticals Co. Ltd.

16.1.15.    Roche Holdings Inc.

17.    Acronyms

Select License Type

Frequently Asked Questions

Growth hormone deficiency (GHD) is a rare but essential cause of short stature with a prevalence of just about one in 4000 in the course of childhood. Although it is a highly unique medical condition, it is crucial to make an accurate diagnosis in order to initiate substitutive recombinant human (rh) GH therapeutic right away and attain a standardization of child development.

The rising incidence of growth hormone (GH) deficiency has become a strain for the healthcare industry in the past couple of years, which is majorly bolstering the growth of the global growth hormone deficiency market.

The global growth hormone deficiency market is segmented on the basis of application, treatment type, end-user, distribution channel and region.

Sandoz International GmbH, Sanofi-Aventis, Pfizer, Novo Nordisk A/S, Teva Pharmaceutical Industries Limited, Ranbaxy, EMD Serono, Inc., Sun Pharmaceutical Industries Ltd., Eli Lilly and Company, Ferring Holding SA, Genentech, Inc., Merck & Co., Inc., Ipsen, GeneScience Pharmaceuticals Co., Ltd., and Roche Holdings, Inc. are the key participating players in the market



This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK